Patients with respiratory conditions, such as asthma and COPD, are being encouraged to use apps to manage their symptoms.
Your patients with chronic obstructive pulmonary disease (COPD) may need help not just coping with their condition but also managing it in their workplace. The symptoms of COPD, a lung and airway ...
Chronic obstructive pulmonary disease is frequently associated with cardiovascular, metabolic, and psychological diseases, all of which can negatively impact quality of life, exacerbations, and ...
GlobalData on MSN
AstraZeneca’s novel COPD drug secures double win in Phase III
GD analyst, Vinie Varkey notes that tozorakimab could capture a "significant patient share" as an add-on therapy in COPD.
The Pulmonary Rehab Program at Topeka's Stormont Vail helps people with chronic lung conditions reach goals for active living ...
—A new study finds that some patients are proactive (they seek immediate treatment), while others tough it out (wishing to avoid the ‘hassle’ or ‘inconvenience’). What can clinicians do to better ...
Please provide your email address to receive an email when new articles are posted on . Pulmonary hypertension appears in 25% to 30% of patients with COPD. There are no approved therapies for patients ...
Most patients with chronic obstructive pulmonary disease (COPD) remain untreated after diagnosis, leading to frequent exacerbations. After COPD diagnosis, prompt and effective single or dual ...
On Friday, AstraZeneca Plc AZN released positive topline data from Phase 3 OBERON and TITANIA trials of tozorakimab in ...
ILAs in patients with COPD are associated with lower lung cancer incidence but higher prevalence of other cancers and heart failure. Patients with ILAs showed significantly lower fibrinogen and ...
AllRock Bio has dosed the first patients in the Phase IIa ROCSTAR clinical trial investigating ROC-101, an oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results